{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles all mention \"Lockdown\" but the passages are either empty or just \"Lockdown\" again. The only meaningful part is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, that's a bit confusing.\n\nFirst, I need to figure out what a lockdown is based on the context given. The main topic here is about the impact of lockdowns on infections, probably related to a pandemic like COVID-19. The user might be looking for a definition of a lockdown in the context of public health measures.\n\nThe context mentions \"non-lockdown\" in the titles, which suggests that the studies or documents are comparing the effects of implementing a lockdown versus not implementing one. The passage that has some content says \"banned Implemented with lockdown.57 24/3/2020\". Maybe \"banned\" here is a typo or part of a larger phrase. Perhaps it's supposed to be \"banned implemented with lockdown\" but that doesn't make much sense. The date 24/3/2020 is March 24, 2020, which is around when many countries started lockdowns. The number 57 could be a reference to a study or a statistic.\n\nSince the context is limited, I need to rely on general knowledge. A lockdown is a public health measure where people are required to stay at home, non-essential businesses are closed, and movement is restricted to prevent the spread of a contagious disease. The context's focus on estimating infections suggests that lockdowns are used to reduce transmission rates. The mention of \"non-lockdown\" implies that without such measures, infection rates might be higher.\n\nThe user might be expecting an answer that defines a lockdown in the context of the provided documents, which are about its impact on infections. Even though the context is sparse, the key points are the implementation of lockdowns and their effect on infection numbers. I should explain that a lockdown is a restrictive measure to limit movement and gatherings to control disease spread, as discussed in the context of estimating infections.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people in order to slow the spread of a contagious disease, such as during a",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look back at the provided context to find the relevant information.\n\nFirst, in the first passage, there's a list of complications from most common to least common. The main ones mentioned are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. That's a good start. \n\nThen, the second part of the passage talks about neonates. It mentions that mothers can transmit CHIKV during the perinatal period, leading to high morbidity. The neonates became symptomatic by day 4, showed common CHIKF symptoms, and six developed meningoencephalitis. So meningoencephalitis is a complication here, especially in newborns. \n\nWait, the first passage already listed meningoencephalitis as a complication. So I need to make sure I include all the complications mentioned. Let me check again. The first list includes respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, and kidney failure. Then the neonate part adds that transmission to neonates can cause meningoencephalitis again, but maybe that's part of the \"other central nervous system problems\" mentioned earlier. Also, the neonates had common CHIKF symptoms, which might include things like fever, rash, joint pain, but the question is about complications, so maybe those are not considered here. The key complications are the ones listed in the first part plus the neonatal transmission leading to severe issues like meningoencephalitis.\n\nSo compiling all the complications from the context: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, kidney failure, and perinatal transmission leading to neonatal complications including meningoencephalitis. Also, the passage mentions that most adults with severe CHIKF have underlying medical conditions, but that's more about risk factors than complications. The answer should list the complications as per the context. Let me make sure I didn't miss any. The answer should list them in order from most common to least as per the first passage, then mention",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about \"Clade A,\" but looking at the passages, the main clades mentioned are 1A, 1B, 1C, etc. The question might have a typo, perhaps referring to Clade 1A instead of Clade A. Let me check the passages again.\n\nIn the first passage, it mentions the 1A lineage containing 1,889 viruses from 34 countries collected from 2010 to the present. It also talks about refining the classification of 1A into three second-order divisions. There's also mention of 1A.1 and 1A.1.1 as exceptions in the within-clade APD. \n\nAnother passage refers to the 1C lineage with viruses from China and South Korea. The 1B clades have issues with splitting due to not meeting criteria. The user's question is about Clade A, but the text uses 1A, 1B, 1C. Maybe \"Clade A\" is a misreference to 1A? Since there's no mention of a standalone \"Clade A\" in the provided passages, but there's a 1A lineage. \n\nSo, if the question is about Clade 1A, then the answer would be that it contains 1,889 viruses from 34 countries collected from 2010 to the present, and it's divided into three second-order divisions. However, the user wrote \"Clade A,\" which isn't directly mentioned. But given the context, it's possible that the intended answer refers to 1A. Alternatively, maybe there's a misunderstanding. Let me check again.\n\nLooking at the titles and passages, all clades are numbered with 1A, 1B, 1C, etc., as part of their lineage. There's no standalone \"Clade A\" mentioned. Therefore, the answer might be that there's no Clade A in the provided context, but if the user meant 1A, then the answer is as above. Since the user might have made a typo, I should address that in the answer, perhaps noting the possible confusion and providing the info on 1A.\n</think>\n\nThe provided context does not explicitly mention a \"Clade A.\" However, it does reference **",
      "retrieved_chunks": [
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations .",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 ."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.15384615384615385,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. It also notes that the core domain of the RBD (receptor binding domain) is highly conserved. \n\nSo, the key points here are the 70% identity and the conserved RBD core. The S1 subunit is part of the spike protein, which is important for viral entry into host cells. The RBD is crucial for binding to the host receptor, so conservation there might mean similar mechanisms of infection.\n\nWait, the context also says that unlike 2019-nCoV and human SARS-CoV, most bat SARSr-CoVs have deletions in the spike receptor binding domain. But the question is about S1 subunits. The S1 subunit includes the RBD, so maybe the deletions in bat CoVs affect the S1 subunit's structure or function compared to 2019-nCoV and human SARS-CoV. However, the specific comparison here is about identity percentage and conservation in the RBD core.\n\nThe answer should state that the S1 subunit of 2019-nCoV has about 70% identity with SARS-like CoVs and human SARS-CoV, and that the RBD core is highly conserved. Also, note that bat SARSr-CoVs have deletions in the RBD, but the question is about S1 subunit comparison. So maybe the deletions are part of the S1 subunit? The passage says \"most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.\" Since the RBD is part of the S1 subunit, those deletions would affect the S1 subunit's structure in bat viruses compared to 2019-nCoV and human SARS-CoV. But the question is about how the S1 subunits compare between 2019-nCoV and the others. So the",
      "retrieved_chunks": [
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from two passages.\n\nFirst, I need to look through the given context. The first passage mentions that Bacillus species, specifically subtilis, are found in traditional fermented foods and are used in probiotics like Biosubtyl, Biosporin, etc. It also says they're used in food industry as starter cultures. The second passage talks about how Bacillus genus was not considered part of the normal intestinal microbiome but now they're found in feces. It specifically states that Bacillus subtilis produces surfactins, fengycins, and iturins in a certain ratio. The surfactins have antimicrobial and antiviral properties. Also, it mentions that B. subtilis helps restore gut microflora by increasing beneficial bacteria and reducing harmful ones.\n\nSo putting this together, Bacillus subtilis is a species of Bacillus that's used in probiotics and fermented foods. It produces certain lipopeptides with antimicrobial and antiviral effects. It's beneficial for gut health by balancing the microbiome. The answer should include its role in probiotics, its production of specific compounds, and its effect on gut flora. Need to make sure not to include any other species unless necessary. Also, check if there's any other info in the context that's relevant. The first passage lists some commercial probiotics that include it, so maybe mention that it's used in those products. Also, note that unlike Lactobacillus, it wasn't considered part of the normal microbiome before but is now recognized for its benefits. The answer should be concise but cover all key points from the context.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus historically found in traditional fermented foods and widely used as a probiotic. It is recognized for producing lipopeptides such as surfactins, fengycins, and iturins, which exhibit antimicrobial and antiviral properties. Specifically, surfactins, though less abundant, have a broad antimicrobial range. B. subtilis supports gut health by restoring microbial balance: it promotes beneficial species like *Bifidobacterium*, *Lactobacillus*, and *Butyricicoccus* while reducing harmful species such as *Acinetobacter*, *Ruminococcus",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action .",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context about the 1889 pandemic. It mentions three major waves from 1889 to 1892, with the 1892 wave being the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, the 1918 pandemic is known for having multiple waves, so maybe this isn't directly relevant unless they're discussing single-wave aspects. The context also mentions viruses with similar genomes in early 1918 before the recognized pandemic. Not sure if this is about single-wave yet.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It talks about convalescent plasma treatment and studies on the origin of the strain. The 2009 pandemic had multiple waves, but the research here is about their response and origin, not necessarily about single-wave pandemics. Maybe not directly relevant.\n\nThird context discusses economic analysis of mitigation strategies for five pandemic severity categories. It references previous studies using simulation models and extends them by considering different severities and interventions. The 2009 pandemic data was used for probabilities. This is more about strategies rather than the pandemic's wave structure.\n\nFourth context is about influenza virus circulation in Taiwan from 2008-2014, focusing on the 2009 pH1N1 pandemic. They used a Richards model variation for multi-wave epidemics, distinguishing turning points. The 2009 pandemic had multiple waves, so this might not be about single-wave. However, the study is on temporal patterns and control of pH1N1, which is multi-wave.\n\nNow, the question is about severe, single-wave pandemics. The provided contexts don't explicitly mention single-wave pandemics. The 1889 example had three waves, 1918 had multiple, 2009 also multiple. The research mentioned in the contexts is on multi-wave pandemics. The user is asking about past research on single-wave, but the contexts don't provide examples of that. However, maybe the first context's mention of the 1889 pandemic's",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the context provided. The user is asking for the total number of reported viral pneumonia cases from Hong Kong, Macao, and Taiwan of China. \n\nFirst, I need to look through the provided passages to find any mention of these regions. Let me go through each one step by step.\n\nThe first passage talks about the 2009 H1N1 pandemic and bacterial co-infections. It mentions 77 fatal cases, but there's no mention of Hong Kong, Macao, or Taiwan here. The second passage is about pneumonia in adults with seasonal influenza in the US from 2005\u20132008. Again, no mention of the regions we're interested in.\n\nThe third passage is another clinical review about influenza attack rates, using an example from La Gloria, Veracruz. That's in Mexico, not the regions we need. The fourth passage is about the 2019-nCoV (now known as COVID-19) and mentions cases in China. Here's the key part: \"At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces...\" Wait, the user specified Hong Kong, Macao, and Taiwan. But this passage says \"30 provinces,\" which in China's administrative divisions would not include Hong Kong, Macao, or Taiwan, as they are separate regions with different statuses. However, sometimes in Chinese official reports, they might refer to provinces and municipalities directly under the central government, but not the special administrative regions or Taiwan. \n\nBut the problem is, the context doesn't explicitly mention the numbers for Hong Kong, Macao, and Taiwan. The fourth passage only gives total numbers for the mainland provinces. The user's question is specifically about those three regions. Since the provided context doesn't include any data on confirmed cases from Hong Kong, Macao, or Taiwan, the answer would be that there's no information provided in the context. However, I need to check again to make sure I didn't miss any other passages.\n\nLooking back, the other passages don't mention any specific regions except the US and Mexico. The fourth passage is about China's National Health Commission",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it starts with \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination in studies from 2015 but doesn't talk about the methods used. The third passage discusses genome analyses focusing on specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage talks about genetic makeup and lineages swapping material but not the analysis methods. \n\nSo the first passage clearly states that high throughput or deep sequencing is the primary method. The answer should be that most analysis has been done using high throughput or deep sequencing methods for complete genome deduction. I need to present this answer concisely, making sure to include the key terms from the passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "The technique can produce genomic .",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the methods mentioned.\n\nFirst context: They mention monitoring GFP expression during passaging using immunofluorescence microscopy with a GFP antibody. But the question is about tracking the spread, so maybe that's part of it, but not the main method.\n\nSecond context: The title is about influenza viruses with reporter genes. The passage says that GFP was observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging. Also, flow cytometry was used to analyze infection progression in antigen-presenting cells. So IVIS (which I think is In Vivo Imaging System) and flow cytometry are methods here. Also, imaging of murine lungs showed infection starting in the respiratory tract and spreading deeper. So maybe they used imaging techniques like IVIS and possibly microscopy for the lungs.\n\nThird context: They monitored plates with an inverted fluorescence microscope until GFP expression was seen. That's in vitro, maybe looking at cell cultures.\n\nFourth context: Talks about expressing fluorescent proteins using certain promoters for in vivo imaging, specifically multi-photon intravital microscopy. That's a more advanced microscopy technique for live tissues.\n\nPutting it all together, the answer should include the different imaging methods used across the studies. The main ones are IVIS for whole-organ imaging, flow cytometry for analyzing specific cell populations, inverted fluorescence microscopy for in vitro tracking, and multi-photon intravital microscopy for in vivo studies. Also, immunofluorescence microscopy with GFP antibodies was used in the first context. But the question is about tracking the spread, which likely involves in vivo methods like IVIS and intravital microscopy, along with ex vivo imaging and flow cytometry. Need to check which of these are explicitly mentioned in the contexts provided.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using a combination of imaging techniques. Specifically:  \n1. **Whole-organ imaging** of infected mouse lungs was performed **ex vivo** using **IVIS** (In Vivo Imaging System) to observe GFP expression.  \n2. **Flow cytometry** was employed to analyze infection progression in antigen-presenting cells.  \n3. **Multi-photon intravital microscopy** was used for in vivo visualization of viral infection dynamics.  \n4. **Inverted fluorescence microscopy** monitored GFP expression",
      "retrieved_chunks": [
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT scanner needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe they mean that even though the CT is noncontaminated, they still follow procedures. Alternatively, maybe there's a typo and they mean contaminated. But given the context, the main idea is that after the exam, they disinfect the equipment right away.\n\nSo the answer should state that the recommended procedure is to disinfect the CT scanner immediately after the examination using the specified sterilization procedures. The answer should probably mention that it's done right after the exam and that they prepare to do so. The exact steps aren't detailed in the context, but the key is the timing and the action taken.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that healthcare personnel prepare to disinfect the CT scanner promptly after a suspected COVID-19 case to prevent contamination, ensuring safety and adherence to emergency management guidelines. Specific steps likely include using approved disinfectants and following institutional protocols for high-touch surfaces and equipment.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}